Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Licorice gargle is a botanical preparation derived from the roots of *Glycyrrhiza glabra* (licorice), utilized for its anti-inflammatory, demulcent, and soothing properties. In clinical settings, particularly perioperative care, it is administered as a gargle to prevent or mitigate postoperative sore throat (POST) and hoarseness following general anesthesia with endotracheal intubation or other airway devices. The therapeutic effects are primarily attributed to active constituents such as glycyrrhizin (glycyrrhizic acid) and glycyrrhetinic acid. These compounds are thought to reduce mucosal inflammation by inhibiting the enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD), thereby increasing local cortisol levels, and by suppressing the production of pro-inflammatory cytokines and mediators like prostaglandin E2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on licorice gargle.